Literature DB >> 19118030

Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/lymphoma.

Masao Nakagawa1, Aya Nakagawa-Oshiro, Sivasundaram Karnan, Hiroyuki Tagawa, Atae Utsunomiya, Shigeo Nakamura, Ichiro Takeuchi, Koichi Ohshima, Masao Seto.   

Abstract

PURPOSE: Peripheral T-cell lymphoma, unspecified (PTCL-U) comprises histopathologically and clinically heterogeneous groups. The purpose of this study was to identify subgroups with distinct genetic, histopathologic, and prognostic features. EXPERIMENTAL
DESIGN: We used array comparative genomic hybridization (CGH) for high-resolution analysis of 51 PTCL-U patients and the array data for examining possible correlations of histopathologic and clinical features. Moreover, we compared the genetic, histopathologic, and prognostic features of the PTCL-U cases with those of 59 cases of lymphoma-type adult T-cell leukemia/lymphoma (ATLL).
RESULTS: We identified 32 regions with frequent genomic imbalance, 1 region with high copy number gain at 14q32.2, and 1 region with homozygous loss at 9p21.3. Gains of 7p and 7q and loss of 9p21.3 showed a significant association with poor prognosis. PTCL-U cases with genomic imbalance showed distinct histopathologic and prognostic features compared with such cases without alteration and a marked genetic, histopathologic, and prognostic resemblance to lymphoma-type ATLL.
CONCLUSIONS: The array CGH enabled us to identify the frequently altered genomic regions with strong prognostic power among PTCL-U cases. A correlative analysis using the array CGH data disclosed a subgroup in PTCL-U with genomic alterations and with histopathologic and clinical relevance. In addition to histopathologic similarity, the strong genetic and prognostic resemblance between PTCL-U cases with genomic imbalance detected by array CGH and lymphoma-type ATLL seems to support the notion that the former may constitute a distinct PTCL-U subgroup.

Entities:  

Mesh:

Year:  2009        PMID: 19118030     DOI: 10.1158/1078-0432.CCR-08-1808

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  20 in total

1.  Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.

Authors:  Rachael Thomas; Eric L Seiser; Alison Motsinger-Reif; Luke Borst; Victor E Valli; Kathryn Kelley; Steven E Suter; David Argyle; Kristine Burgess; Jerold Bell; Kerstin Lindblad-Toh; Jaime F Modiano; Matthew Breen
Journal:  Leuk Lymphoma       Date:  2011-03-07

2.  Clinicopathological analysis in PTCL-NOS with CADM1 expression.

Authors:  Takeharu Kato; Hiroaki Miyoshi; Seiichiro Kobayashi; Noriaki Yoshida; Yoshitaka Imaizumi; Masao Seto; Kaoru Uchimaru; Yasushi Miyazaki; Koichi Ohshima
Journal:  Virchows Arch       Date:  2017-09-22       Impact factor: 4.064

3.  Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.

Authors:  Masao Nakagawa; Shinobu Tsuzuki; Keiichiro Honma; Osamu Taguchi; Masao Seto
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

Review 4.  Molecular genetics of peripheral T-cell lymphomas.

Authors:  Pier Paolo Piccaluga; Valentina Tabanelli; Stefano A Pileri
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

Review 5.  Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.

Authors:  Swaminathan P Iyer; Francine F Foss
Journal:  Oncologist       Date:  2015-06-22

6.  Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Authors:  Tayla B Heavican; Alyssa Bouska; Jiayu Yu; Waseem Lone; Catalina Amador; Qiang Gong; Weiwei Zhang; Yuping Li; Bhavana J Dave; Maarja-Liisa Nairismägi; Timothy C Greiner; Julie Vose; Dennis D Weisenburger; Cynthia Lachel; Chao Wang; Kai Fu; Jadd M Stevens; Soon Thye Lim; Choon Kiat Ong; Randy D Gascoyne; Edoardo Missiaglia; Francois Lemonnier; Corinne Haioun; Sylvia Hartmann; Martin Bjerregård Pedersen; Maria Antonella Laginestra; Ryan A Wilcox; Bin Tean Teh; Noriaki Yoshida; Koichi Ohshima; Masao Seto; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Elaine S Jaffe; Rita M Braziel; Francesco d'Amore; Giorgio Inghirami; Francesco Bertoni; Laurence de Leval; Philippe Gaulard; Louis M Staudt; Timothy W McKeithan; Stefano Pileri; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

Review 7.  Genomic profiles in B cell lymphoma.

Authors:  Masao Seto
Journal:  Int J Hematol       Date:  2010-08-27       Impact factor: 2.490

Review 8.  Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Authors:  Noriaki Yoshida; Dai Chihara
Journal:  Curr Treat Options Oncol       Date:  2015-02

9.  Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.

Authors:  Maja Ludvigsen; Martin Bjerregård Pedersen; Kristina Lystlund Lauridsen; Tim Svenstrup Poulsen; Stephen Jacques Hamilton-Dutoit; Søren Besenbacher; Knud Bendix; Michael Boe Møller; Peter Nørgaard; Francesco d'Amore; Bent Honoré
Journal:  Blood Adv       Date:  2018-10-09

Review 10.  Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.

Authors:  Mamiko Sakata-Yanagimoto; Kota Fukumoto; Kennosuke Karube; Shigeru Chiba
Journal:  J Clin Exp Hematop       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.